首页> 外文OA文献 >Mixed backbone antisense glucosylceramide synthase oligonucleotide (MBO-asGCS) loaded solid lipid nanoparticles: In vitro characterization and reversal of multidrug resistance in NCI/ADR-RES cells

【2h】

Mixed backbone antisense glucosylceramide synthase oligonucleotide (MBO-asGCS) loaded solid lipid nanoparticles: In vitro characterization and reversal of multidrug resistance in NCI/ADR-RES cells

机译：混合骨干反义葡萄糖苷酰胺合成酶寡核苷酸（MBO-ASGCS）负载固体脂质纳米颗粒：NCI / ADR-RES细胞中的多药耐药体的体外表征和逆转

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Akhtar Siddiqui; Gauri Anand Patwardhan; Yong-Yu Liu; Sami Nazzal;
展开▼
作者单位

展开▼
年度 2010
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献

1. Mixed backbone antisense glucosylceramide synthase oligonucleotide (MBO-asGCS) loaded solid lipid nanoparticles: in vitro characterization and reversal of multidrug resistance in NCI/ADR-RES cells. [J] . Siddiqui A, Patwardhan GA, Liu YY, International Journal of Pharmaceutics . 2010,第1a2期

机译：混合的主链反义葡糖神经酰胺合酶寡核苷酸（MBO-asGCS）负载的固体脂质纳米颗粒：NCI / ADR-RES细胞中多药耐药性的体外表征和逆转。
2. Doxorubicin and MBO-asGCS oligonucleotide loaded lipid nanoparticles overcome multidrug resistance in adriamycin resistant ovarian cancer cells (NCI/ADR-RES) [J] . SiddiquiA., GuptaV., LiuY.-Y., International Journal of Pharmaceutics . 2012,第1a2期

机译：阿霉素和MBO-asGCS寡核苷酸负载的脂质纳米颗粒克服了对阿霉素耐药的卵巢癌细胞（NCI / ADR-RES）的多药耐药性
3. Preparation and Multidrug Resistance Reversal Study of Psoralen-Loaded Solid Lipid Nanoparticles [J] . Huang Yinghong, Ning Jie, Zhou Tiantian, Journal of biomaterials and tissue engineering . 2015,第10期

机译：补骨脂素固体脂质纳米粒的制备及多药逆转研究
4. Doxorubicin-loaded Solid Lipid Nanoparticles to Overcome Multidrug Resistance in Cancer Therapy [C] . Sang-Wan Seo, Robhash-Kusam Subedi, Keon Wook Kang, Annual meeting exposition of the Controlled Release Society . 2009

机译：载有阿霉素的固体脂质纳米颗粒可克服癌症治疗中的多药耐药性
5. Formulation and characterization of solid lipid nanoparticles (SLN) for mixed backbone antisense oligonucleotide (MBO-asGCS) and doxorubicin delivery. [D] . Siddiqui, Akhtar Rasheed. 2011

机译：用于混合主链反义寡核苷酸（MBO-asGCS）和阿霉素递送的固体脂质纳米颗粒（SLN）的配制和表征。
6. Mixed Backbone Antisense Glucosylceramide Synthase Oligonucleotide (MBO-asGCS) loaded Solid Lipid Nanoparticles: In Vitro Characterization and Reversal of Multidrug Resistance in NCI/ADR-RES Cells [O] . Akhtar Siddiqui, Gauri Anand Patwardhan, Young-Yu Liu, -1

机译：混合骨干反义葡萄糖苷酰胺合成酶寡核苷酸（MBO-ASGCS）负载固体脂质纳米颗粒：NCI / ADR-RES细胞中的多药耐药体的体外表征和逆转
7. Doxorubicin and MBO-asGCS oligonucleotide loaded lipid nanoparticles overcome multidrug resistance in adriamycin resistant ovarian cancer cells (NCI/ADR-RES) [O] . Akhtar Siddiqui, Vineet Gupta, Yong-Yu Liu, 2012

机译：多柔比星和MBO-ASGCS寡核苷酸负载脂质纳米颗粒克服亚霉素抗性卵巢癌细胞中的多药耐药性（NCI / ADR-RES）
8. Antisense Oligonucleotides to Glucosylceramide Synthase Can Reverse Multidrug Resistance in Breast Cancer [R] . Liu, Y. 2002

机译：葡萄糖神经酰胺合成酶的反义寡核苷酸可以逆转乳腺癌的多药耐药性

Mixed backbone antisense glucosylceramide synthase oligonucleotide (MBO-asGCS) loaded solid lipid nanoparticles: In vitro characterization and reversal of multidrug resistance in NCI/ADR-RES cells

著录项

相似文献

相关主题

期刊订阅